Hepatitis C virus core protein induces hypoxia-inducible factor 1α-mediated vascular endothelial growth factor expression in Huh7.5.1 cells

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 2010-2014

  Zhu, Chengliang ^a   Liu, Xinghui ^b   Wang, Shiqun ^c   Yan, Xiaohong ^c   Tang, Zhaoming ^c   Wu, Kailang ^c   Li, Yan ^a   Liu, Fang ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Hypoxia inducible factor 1 ; Vascular endothelial growth factor

Indexed keywords

CORE PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN SECRETION; RNA INTERFERENCE; UPREGULATION;

CELL LINE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RNA INTERFERENCE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL CORE PROTEINS;

EID: 84899552776     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2039     Document Type: Article

References (31)

1. Raimondi S, Bruno S, Mondelli MU and Maisonneuve P: Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 50: 1142-1154, 2009.
2. Yotsuyanagi H, Koike K, Yasuda K, et al: Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 76: 1352-1355, 1995.
3. De Francesco R: Molecular virology of the hepatitis C virus. J Hepatol 31 (Suppl 1): 47-53, 1999.
4. Rosenberg S: Recent advances in the molecular biology of hepatitis C virus. J Mol Biol 313: 451-464, 2001.
5. Suzuki R, Suzuki T, Ishii K, Matsuura Y and Miyamura T: Processing and functions of Hepatitis C virus proteins. Intervirology 42: 145-152, 1999.
6. Duong FH, Filipowicz M, Tripodi M, La Monica N and Heim MH: Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126: 263-277, 2004.
7. Jones DM, Patel AH, Targett-Adams P and McLauchlan J: The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J Virol 83: 2163-2177, 2009.
8. Park CY, Jun HJ, Wakita T, Cheong JH and Hwang SB: Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 284: 9237-9246, 2009.
9. Wagoner J, Austin M, Green J, et al: Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol 81: 309-318, 2007.
10. Yi M, Ma Y, Yates J and Lemon SM: Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog 5: e1000403, 2009.
11. Semenza GL: Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106, 2009.
12. Roos-Mattjus P and Sistonen L: The ubiquitin-proteasome pathway. Ann Med 36: 285-295, 2004.
13. Shemirani B and Crowe DL: Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases. Oral Oncol 38: 251-257, 2002.
14. Shi YH and Fang WG: Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol 10: 1082-1087, 2004.
15. Nasimuzzaman M, Waris G, Mikolon D, Stupack DG and Siddiqui A: Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. J Virol 81: 10249-10257, 2007.
16. Gillespie DL, Flynn JR, Ragel BT, et al: Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo. Methods Mol Biol 487: 283-301, 2009.
17. Katoh R, Miyagi E, Kawaoi A, et al: Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasms. Hum Pathol 30: 891-897, 1999.
18. Machein MR and Plate KH: VEGF in brain tumors. J Neurooncol 50: 109-120, 2000.
19. Banerjee A, Ray RB and Ray R: Oncogenic potential of hepatitis C virus proteins. Viruses 2: 2108-2133, 2010.
20. McGivern DR and Lemon SM: Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30: 1969-1983, 2011.
21. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067, 1998.
22. Chun SY, Johnson C, Washburn JG, Cruz-Correa MR, Dang DT and Dang LH: Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1alpha and HIF-2alpha target genes. Mol Cancer 9: 293, 2010.
23. Doronkin S, Djagaeva I, Nagle ME, Reiter LT and Seagroves TN: Dose-dependent modulation of HIF-1alpha/sima controls the rate of cell migration and invasion in Drosophila ovary border cells. Oncogene 29: 1123-1134, 2010.
24. Talks KL, Turley H, Gatter KC, et al: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157: 411-421, 2000.
25. Wong C, Wellman TL and Lounsbury KM: VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. Gynecol Oncol 91: 513-517, 2003.
26. Moon EJ, Jeong CH, Jeong JW, et al: Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. FASEB J 18: 382-384, 2004.
27. Tomita M, Semenza GL, Michiels C, et al: Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Biochem J 406: 317-323, 2007.
28. Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M and Pagano JS: Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 24: 5223-5234, 2004.
29. Zhang EY and Tang XD: Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer. Asian Pac J Cancer Prev 13: 5363-5369, 2012.
30. Markert EK, Levine AJ and Vazquez A: Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis 3: e397, 2012.
31. Smirnova IS, Aksenov ND, Kashuba EV, et al: Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability. Cell Oncol: 28: 177-190, 2006.